Steve Aselage

Affiliations

  • Director at Biocryst Pharmaceuticals Inc (BCRX), 2024-06-14
  • Director at Acer Therapeutics Inc. (ACER), 2023-11-20
  • Director at Travere Therapeutics Inc. (TVTX), 2022-05-13
  • Evp, Chief Business Officer at Biomarin Pharmaceutical Inc (BMRN), 2012-07-05
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
BCRX $6.40 2,500 $16,000.00 2,500 2024-05-24 Filing
ACER $1.22 409,836 $499,999.92 483,741 2022-11-29 Filing
ACER $2.04 7,984 $16,287.36 73,905 2021-12-10 Filing
ACER $2.15 2,016 $4,334.40 65,921 2021-12-09 Filing
ACER $3.50 45,000 $157,500.00 63,905 2020-07-24 Filing
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
TVTX $21.92 2,575 $56,456.62 146,919 2022-05-11 Filing
TVTX $29.39 31,800 $934,602.00 149,494 2021-11-16 Filing
TVTX $26.23 10,000 $262,300.00 161,794 2021-11-05 Filing
TVTX $30.00 3,500 $105,000.00 19,500 2021-11-02 Filing
TVTX $29.48 5,000 $147,400.00 23,000 2021-11-01 Filing